TRANSPLANT ABSCESS

TRANSPLANT ABSCESS was reported 46 times

TRANSPLANT ABSCESS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 6 0.0047
1 Antimalarial [EPC] 6 0.0006
2 Antiprotozoal [EPC] 6 0.0006
3 Antimetabolite Immunosuppressant [EPC] 10 0.0005
4 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 1 0.0003
5 Selective T Cell Costimulation Blocker [EPC] 1 0.0002
6 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0001
7 Calcineurin Inhibitor Immunosuppressant [EPC] 11 0.0001
8 Penem Antibacterial [EPC] 2 0.0001
9 Human Immunoglobulin G [EPC] 1 0.0000
10 Bile Acid [EPC] 1 0.0000
11 Nucleoside Analog Antiviral [EPC] 3 0.0000
12 Purine Antimetabolite [EPC] 3 0.0000
13 Corticosteroid [EPC] 29 0.0000
14 Protease Inhibitor [EPC] 1 0.0000
15 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
16 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
17 Macrolide Antimicrobial [EPC] 1 0.0000
18 Complement Inhibitor [EPC] 1 0.0000
19 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
20 Fluoroquinolone Antibacterial [EPC] 2 0.0000
21 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
22 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
24 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
25 Thiazide Diuretic [EPC] 1 0.0000
26 Platinum-based Drug [EPC] 1 0.0000
27 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
28 Vitamin D [EPC] 1 0.0000
29 Vitamin B12 [EPC] 1 0.0000
30 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
31 Vitamin C [EPC] 1 0.0000
32 Insulin Analog [EPC] 1 0.0000
33 Kinase Inhibitor [EPC] 1 0.0000
34 Platelet Aggregation Inhibitor [EPC] 1 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000